Your browser doesn't support javascript.
loading
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study.
Maese, Luke; Loh, Mignon L; Choi, Mi Rim; Lin, Tong; Aoki, Etsuko; Zanette, Michelle; Agarwal, Shirali; Iannone, Robert; Silverman, Jeffrey A; Silverman, Lewis B; Raetz, Elizabeth A; Rau, Rachel E.
  • Maese L; Huntsman Cancer Institute, University of Utah, Primary Children's Hospital, Salt Lake City, UT.
  • Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute and Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA.
  • Choi MR; Jazz Pharmaceuticals, Palo Alto, CA.
  • Lin T; Jazz Pharmaceuticals, Palo Alto, CA.
  • Aoki E; Jazz Pharmaceuticals, Palo Alto, CA.
  • Zanette M; Jazz Pharmaceuticals, Philadelphia, PA.
  • Agarwal S; Jazz Pharmaceuticals, Palo Alto, CA.
  • Iannone R; Jazz Pharmaceuticals, Philadelphia, PA.
  • Silverman JA; Jazz Pharmaceuticals, Palo Alto, CA.
  • Silverman LB; Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, MA.
  • Raetz EA; Division of Pediatric Hematology and Oncology, Department of Pediatrics, New York University Langone Health, New York, NY.
  • Rau RE; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX.
Blood ; 141(7): 704-712, 2023 02 16.
Article en En | MEDLINE | ID: mdl-36108304
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipersensibilidad a las Drogas / Erwinia / Leucemia-Linfoma Linfoblástico de Células Precursoras / Hipersensibilidad / Antineoplásicos Límite: Child / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipersensibilidad a las Drogas / Erwinia / Leucemia-Linfoma Linfoblástico de Células Precursoras / Hipersensibilidad / Antineoplásicos Límite: Child / Humans Idioma: En Año: 2023 Tipo del documento: Article